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Objectives: Brain imaging studies carried out in patients suffering from generalized anxiety disorder
(GAD) have contributed to better characterize the pathophysiological mechanisms underlying this
disorder. The present study reviews the available functional and structural brain imaging evidence on
GAD, and suggests further strategies for investigations in this field.
Methods: A systematic literature review was performed in PubMed, PsycINFO, and Google Scholar,
aiming to identify original research evaluating GAD patients with the use of structural and functional
magnetic resonance imaging as well as diffusion tensor imaging.
Results: The available studies have shown impairments in ventrolateral and dorsolateral prefrontal
cortex, anterior cingulate, posterior parietal regions, and amygdala in both pediatric and adult GAD
patients, mostly in the right hemisphere. However, the literature is often tentative, given that most
studies have employed small samples and included patients with comorbidities or in current use of
various medications. Finally, different methodological aspects, such as the type of imaging equipment
used, also complicate the generalizability of the findings.
Conclusions: Longitudinal neuroimaging studies with larger samples of both juvenile and adult GAD
patients, as well as at risk individuals and unaffected relatives, should be carried out in order to shed
light on the specific biological signature of GAD.
Keywords: Generalized anxiety disorder; magnetic resonance imaging; functional MRI; diffusion
tensor imaging; resting-state
Introduction
Anxiety disorders share common features, including
excessive and irrational fear and avoidance of anxiety
triggers. I˙n particular, generalized anxiety disorder (GAD)
is a severe chronic illness characterized by symptoms
including persistent and uncontrollable worry about every-
day life matters and social competence, as well as auto-
nomic hyperarousal and tension.1 The prevalence of
GAD, which typically begins in young adulthood, is about
2% in the adult population; the lifetime prevalence of GAD
is around 4.7%.2,3 Female sex, low socioeconomic status,
and exposure to childhood adversity are considered as
risk factors for the disease.4
Despite the suffering, disability, and economic burden
associated with GAD,5,6 treatment options are not avai-
lable for a considerable group of patients because little is
known about the pathophysiology of this disease.7 There-
fore, in recent years, researchers have focused their
attention towards the investigation of the neurobiological
underpinnings of GAD.8 In the past two decades, imaging
studies have identified subtle structural, chemical, and
functional brain changes in GAD that provide hints on
the neurophysiologic mechanisms underlying this illness.
Specifically, GAD symptoms have been linked to a dis-
ruption in the balance of activity in the emotional centers
of the brain rather than in the higher cognitive centers.9,10
Indeed, the initial processing of stressful stimuli is carried
out by a neural circuit composed of core limbic structures,
including the amygdala, insula, periaqueductal gray matter,
locus coeruleus, and hypothalamus. These structures are
responsible for an early evaluation of stressful stimuli and
for organizing an appropriate initial physiological and
behavioral response.11 Moreover, studies have shown that
in GAD patients the pattern of brain activity resembles that
of animal models in which limbic circuits, particularly the
amygdala, play an important role in fear response.12-14
Etkin et al.15 have also found evidence of an intra-amygdala
abnormality with engagement of a compensatory fronto-
parietal executive control network, consistent with cognitive
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theories of GAD. Interestingly, a recent review reported
selective metabolic dysfunctions in regions within the
prefrontal-limbic network, including the dorsolateral pre-
frontal cortex (DLPFC) and hippocampus.16
Furthermore, in addition to the amygdala, other cortical
and subcortical regions have been found to be involved in
the pathophysiology of this disabling disorder. Functional
magnetic resonance imaging (fMRI) research has reported
that hypoactivation of the DLPFC in GAD patients was
associated with emotional dysregulation and deficits in
attentional control, ultimately suggesting that the failure to
engage prefrontal cortex (PFC) during emotion regulation
may be part of the critical transition from dispositional high
anxiety to an anxiety disorder.17-19 Additionally, evidence
from structural MRI studies showed that GAD is character-
ized by selective impairments in the cortex, especially in
regions within the prefrontal-temporal network, and sub-
cortex, including basal ganglia and amygdala, in both adult
and pediatric cohorts.20-25
With regard to neurochemistry, a number of neuro-
transmitter systems have been implicated in the neuro-
biology of GAD.16,26,27 Given the known pharmacological
and clinical effects of benzodiazepines, the g-aminobu-
tyric acid (GABA)/benzodiazepine system has become a
focus of research in GAD. Indeed, several studies showed
that GAD patients have reduced central benzodiazepine
receptor function, perhaps due to alterations in receptor
number.28-30 However, this neurotransmitter system was
not the only one found to be disrupted in GAD; other
studies have also reported a key role of the norepinephr-
ine31,32 and serotonin26 systems, resulting mainly from
their involvement in neural mechanisms, such as sensiti-
zation and fear conditioning, consistently associated with
stress.33,34
Considering this scenario, summarizing the available
neuroimaging evidence on GAD is important to provide a
consistent overview of the neural systems found to be
disrupted in this disorder. The debate regarding these
findings, with suggestions for future investigation in this
field, may help elucidate the pathophysiological mechan-
isms involved in GAD and guide the development of more
effective treatment strategies.35,36
Methods
A systematic literature search was performed in PubMed,
PsycINFO, and Google Scholar, using the following key-
words: ‘‘Generalized anxiety disorder’’ OR ‘‘GAD’’ AND
(‘‘Magnetic Resonance Imaging’’ OR ‘‘MRI’’ OR ‘‘Diffusion
Tensor Imaging’’ OR ‘‘DTI’’ OR ‘‘Diffusion Weighted
Imaging’’ OR ‘‘DWI’’ OR ‘‘resting-state functional Mag-
netic Resonance’’ OR ‘‘rs-FMRI,’’ OR ‘‘functional MRI,’’
OR ‘‘fMRI’’). Considering the scope of the present work,
the following inclusion criteria were considered: original
research evaluating pediatric, adolescent, adult, and
elderly GAD patients with structural\functional MRI and
diffusion tensor imaging (DTI). Studies investigating the
effect of psychotropic medications on the brain were also
included. No time limits were set and the last search was
conducted in June 2018.
The search identified 199 articles, of which 110 were
excluded for the following reasons: a) lack of control
group; b) not being published in English; c) GAD patients
were only compared to other diseases, including panic
disorder (PD), social phobia, generalized social anxiety
disorder, separation anxiety disorder, and major depres-
sive disorder; d) GAD was not the primary diagnosis; and
e) did not employ the neuroimaging techniques consid-
ered in this review. The remaining articles (n=89) were
included in this review. Specifically, twenty were about
structural MRI, five about DTI, one about diffusion weighted
imaging, and sixty-three about fMRI. The selection of
studies is summarized in Figure 1.
Putative models of anxiety pathophysiology
Three models have been proposed to describe the
functional anatomy of anxiety disorders.26,37 The first is
the linear model, according to which identical brain
structures are thought to be hyper- or hypo- activated
during the experience of anxiety in health and disease,
depending on the severity of the experience. The second
model is the catastrophe theory model, which assumes
that, after reaching a particular set of conditions, a system
is unable to maintain an equilibrium and a discontinuity
occurs, leading to the activation of specific brain areas in
pathological anxiety. The third and last model, named
the modular model, postulates that all forms of anxiety
activate a module related to the experience of autonomic
arousal and fear; conversely, other areas would only be
activated in the presence of specific forms of anxiety
and linked to specific experiences (i.e., flight reaction as
in a panic attack; immobility as in anticipatory anxiety;
and awareness of one’s own body position in space as
in social phobia). These three models are not mutually
exclusive and may partially coexist. However, the modular
theory provides an integrated explanation that is more
consistent with contemporary models of brain function.38
Reviewing the neuroimaging literature can help to clarify
this question.
Brain imaging studies in GAD
Structural studies
For a detailed description of MRI studies in GAD, please
refer to Table 1 and Supplementary Table S1. To date,
several structural MRI studies have explored changes in
gray matter (GM) and white matter (WM) volumes in GAD
patients. Specifically for GM, the first structural MRI
studies on GAD were carried out by the same research
group on a small group of children and adolescents. The
authors showed abnormally larger superior temporal
gyrus (STG) and amygdala volumes, especially in the
right hemisphere, in GAD patients compared to healthy
controls (HCs).39,40 Interestingly, the same authors also
reported the presence of preserved brain regions in their
juvenile patient population, including intracranial volumes,
total cerebral GM and WM, prefrontal and temporal lobes,
corpus callosum, hippocampus, thalamus, and basal
ganglia.39,40 In contrast, Strawn et al.41 found increased
Braz J Psychiatry. 2019;00(00)
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GM volumes in right precuneus and precentral gyrus, as
well as decreased GM volumes in orbitofrontal cortex
and posterior cingulate in a group of GAD adolescents.
Furthermore, a more recent study from the same group,21
including an independent sample of patients with various
anxiety disorders, extended their previous results by
showing greater GM volumes in left cingulate gyrus and
lower GM volumes in left inferior frontal gyrus, left post-
central gyrus, left precuneus, and amygdala bilaterally.41
Along this line, a study carried out by Mohlman et al.42
also reported that PFC volumes, and especially the medial
orbital cortex, positively correlated with worry severity in
older adults with GAD. Additionally, larger volumes of
amygdala, thalamus, dorsomedial PFC (DMPFC), and
putamen have been found in adolescent and adult
patients suffering from GAD.23,24,43,44 In contrast, a
voxel-based morphometry (VBM) investigation showed
selective volume reduction in left amygdala in pediatric
GAD compared to age- and gender-matched HCs.45
Further, Liao et al.46 found selective gender-related
differences in left precuneus/posterior cingulate cortex,
with males having larger volumes compared to female
GAD patients. Hilbert et al.20 also reported significantly
higher GM volumes in GAD subjects, mainly in basal
ganglia and less consistently in STG, in contrast with
other studies showing GM volume reductions in insula
and STG in GAD patients compared to HCs.44,47,48
Additionally, two studies reported that GAD patients had
lower GM volumes in supramarginal, precentral, and
postcentral gyri bilaterally,44 as well as in the hypotha-
lamus,49 as compared to HCs.49
Finally, a recent MRI study25 exploring different mor-
phological parameters, including cortical surface area,
cortical thickness, GM volumes, and gyrification, reported
no alterations of GM in subjects with GAD compared to
HCs. However, the authors showed a hyper-gyrification in
the right fusiform, right inferior temporal gyrus, right
superior parietal gyrus, supramarginal gyrus bilaterally,
and left superior frontal gyri, as well as reduced cortical
thickness in right caudal middle frontal gyrus in GAD
patients compared to HCs. Overall, this structural MRI
evidence suggests that GAD is a neurobiological disorder
characterized by extensive deficits in selective brain
regions encompassing predominantly the prefrontal-tem-
poro-limbic network, which has been shown to be
implicated in behavioral inhibition,59 modulation of antici-
patory threat,60 and attachment styles,61 abilities that are
often disrupted in GAD patients.62
With regard to WM abnormalities, some DTI studies
provided important evidence of WM and brain connectivity
disruptions in GAD. Specifically, reduced fractional aniso-
tropy (FA), a measure of WM coherence and organiza-
tion, in left uncinate fasciculus, which is a WM pathway
connecting ventral prefrontal-cortex (VPFC) and anterior
cingulate cortex (ACC) to the amygdala and other limbic
regions, was found in patients with GAD, particularly in
subjects without comorbidity.52 Similarly, Zhang et al.53
found an augmentation of FA in the right amygdala and a
Figure 1 Study selection flow chart.DTI = diffusion tensor imaging; DWI = diffusion weighted imaging; GAD = generalized
anxiety disorder; MRI = magnetic resonance imaging.
Braz J Psychiatry. 2019;00(00)
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lower FA in the left ACC. Furthermore, another DTI study
reported that GAD patients had increased FA in right
postcentral gyrus, the location of primary somatosensory
cortex, which has rarely been indicated as a disrupted
brain area in anxiety disorders.51 Additionally, altered
microstructure coherence of the right posterior parietal
cortex and the callosal splenium has been reported in
adult GAD patients in a previous investigation carried out
by our group.50 Interestingly, several studies from the
same research group showed reduced WM volumes in
the midbrain, precentral gyrus, DLPFC, and anterior limb
of the internal capsule in GAD patients compared to
HCs.27,48,56 Moreover, a recent DTI study by Wang
et al.58 examined WM deficits in subjects with GAD and
showed a reduction of FA in many other regions, including
bilateral uncinate fasciculus, body of corpus callosum,
left middle cingulum, bilateral anterior thalamic radiation
and corona radiate, right anterior limb of internal capsule,
bilateral inferior frontal-occipital fasciculus, bilateral super-
ior and inferior longitudinal fasciculus. Finally, Cha et al.57
also found increased mean diffusivity (MD) in hippocampus
in GAD patients compared to HCs.
In conclusion, despite this evidence, it is important to
point out that a general consensus regarding GM and WM
abnormalities in GAD has not been reached yet. Indeed, it
is still not clear whether GAD is associated with increased
or decreased GM and WM volumes in the abovemen-
tioned regions. These discrepancies might be associa-
ted with the inclusion of GAD patients using different
psychotropic medications and/or presenting different com-
orbidities, especially depression or other anxiety disorders,
which could have potentially influenced the results of
the investigations. Indeed, depression and other anxiety
disorders, such as PD, may themselves affect brain
anatomy and development, as suggested by previous
studies.37,63-65 Also, it has been reported that the
presence of comorbidities in GAD exacerbates its clinical
phenotypes by decreasing the responsiveness to treat-
ments and worsening the outcome.66 Moreover, pharma-
cological treatments may have also biased the brain
deficits observed in these patients. In this regard, it has
been suggested that antidepressants may have significant
effects on brain networks by modulating the volumes,
functions, and biochemistry of brain structures.67,68 Inter-
estingly, Dusi et al.67 showed that antidepressants seem
to affect the prefrontal-limbic network by reversing the
hyperactivation of limbic areas to emotional stimuli and by
enhancing frontal cortex and cingulate top-down modula-
tory influence on subcortical structures. Similarly, it has
also been reported that citalopram, a selective serotonin
reuptake inhibitor (SSRI) and a first-line treatment for
anxiety disorders has selective effects on specific brain
regions. For instance, it has been shown that citalopram
attenuated amygdala response to aversive stimuli and
reduced activity in prefrontal regions, striatum, insula,
and paralimbic regions in GAD patients listening to worry
sentences.69 Therefore, from this evidence emerged
that pharmacological treatments might have significant
effects on neural processes, which may potentially
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However, despite these limitations, these results
highlight the importance of investigating GM and WM
alterations in GAD in order to identify the neuroanato-
mical mechanisms associated with cognitive and emotional
dysfunctions often observed in these patients. Future stu-
dies with more homogeneous samples, both from diag-
nostic and pharmacological perspectives, are warranted to
extend the generalizability of the findings.
Functional magnetic resonance imaging (fMRI) studies
The common symptoms of GAD lead to emotional dysre-
gulation, such as unsuppressed anger and low tolerance
to frustration, and/or to cognitive deficits, including impair-
ments of implicit and explicit memories, attention, and
executive function.55,70,71 Therefore, in this section, we
have tried to clarify the main functional brain abnor-
malities in connection with emotional regulation and
cognitive function in patients with GAD.
Specifically, the studies reviewed are divided into
four subsections. The first subsection encompasses the
studies evaluating emotion dysregulations. The second
one is related to research exploring both ‘‘emotion and
cognition.’’ The third subsection focuses on resting-state
fMRI studies, and the fourth analyzes the link between
fMRI and drugs used in GAD patients. All studies eval-
uated in this section are summarized in Table 2 and
Supplementary Table S1.
Emotion regulation deficits in GAD
Emotion dysregulation, a common symptom of GAD, con-
sists of two separate, yet related, abnormalities: atypical
emotional reactivity (ER) and dysregulation of reactivity.128
Specifically, it has been reported that patients with GAD
a) often experience emotions with heightened intensity
compared to individuals without GAD; b) have marked
difficulties identifying, describing, and clarifying their emo-
tional experiences; and c) are prone to greater negative
reactivity to emotions by holding catastrophic beliefs
about the consequences of both negative and positive
emotions.129
Therefore, in recent years, fMRI studies have been
carried out to investigate neural activation deficits in GAD
while processing emotional tasks. An fMRI study by
Guyer et al.83 carried out on pediatric patients with social
phobia and GAD during a monetary incentive delay task
reported an hyperactivation of the putamen in response to
positive-valenced stimuli in GAD patients compared to
HCs and patients with social phobia. Moreover, Cha
et al.96 also described alteration of the nucleus accum-
bens together with high reactivity of the ventral tegmental
area and mesocorticolimbic system in patients with GAD
compared to HCs during a fear generalization task.
Interestingly, Krain et al.76 explored the intolerance of
uncertainty (IU), a trait associated with worry, in pediatric
GAD patients, and showed that high levels of IU were
associated with increased activation in frontal and limbic
regions in these patients compared to HCs. This further
suggests that an altered emotion regulation strategy is a
key disability characterizing GAD.
Furthermore, an exaggerated right amygdala res-
ponse to fearful faces was reported in three small fMRI
studies in children with GAD.72,75,77 Similarly, a recent
study carried out by Buff et al.125 showed a link between
hyperactivation of the amygdala and bed nucleus of the
stria terminalis and the mechanism of threat anticipation in
GAD patients, ultimately underlining the importance of
these two structures in the regulation of anticipatory anxi-
ety. Interestingly, another study from the same research
group120 further reported hyperactivation of the amyg-
dala, along with DMPFC, ventrolateral PFC (VLPFC),
and thalamus, as well as reduced activity in ventrome-
dial PFC (VMPFC) during an ER task in GAD patients
compared to HCs.
In contrast, fMRI studies have also demonstrated decrea-
sed amygdala activation in the presence of negative stimuli
in GAD patients compared with HCs.87,89
Additionally, Greenberg et al.130 showed decreased
recruitment of VMPFC during a fear conditioned stimulus
in adult GAD patients compared to HCs. Similarly, Cha
et al.54 found that VMPFC thickness, functional and
structural connectivity within the corticolimbic system
predicted individual variability of VMPFC threat assess-
ment in an independent fashion. This is not surprising,
especially because VMPFC has been shown to be
involved in the regulation and inhibition of fear response in
other anxiety disorders, such as PTSD and phobias.131
Moreover, increased activation has been observed
in the left medial PFC and right VLPFC in response to
emotional images in a juvenile GAD population.88 Right
VLPFC activity was also examined by Monk et al.74 in a
population of young people with GAD in response to
angry stimuli. The authors describe increased VLPFC
activation during trials containing angry faces in GAD
patients compared to HCs as well as an inverse asso-
ciation between VLPFC activation and the severity of anxiety
symptoms, ultimately suggesting that VLPFC activation may
serve as a compensatory response.
In other studies, GAD patients had increased activation
in prefrontal regions, including the DMPFC and ACC, in
response to worry and neutral stimuli,80 as well as in a
lateral region of the middle frontal gyrus in response to
angry expressions.78 Hyperactivity in prefrontal regions
was further confirmed by more recent studies in which
GAD patients had elevated activity specifically in response
to threat vs. neutral pictures in cingulate cortex, dorsal
anterior insula/frontal operculum, and posterior DLPFC.101
Also, anxiety symptom scores were associated with
increased angry 4 shapes activation in the bilateral
insula, anterior/midcingulate, and DLPFC compared to
HCs.115 In contrast, Yin et al.122 found a significant reduc-
tion of inferior frontal gyrus activity in GAD patients, which
was also negatively correlated with symptom severity.
Furthermore, altered activation and dysfunctional con-
nectivity in and between selective brain regions, includ-
ing amygdala, DLPFC, cingulate, insula, posterior pari-
etal cortex, pregenual ACC (pgACC), and cerebellum,
were consistently found in adolescents and adults with
GAD,15,81,84,90,95,122 especially during tasks involved in
self-referential processing132,133 and mentalization,134
abilities often found altered in GAD.135 Similarly, a recent
Braz J Psychiatry. 2019;00(00)
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study exploring brain coupling within regions of the default-
mode network (DMN), including ACC and DMPFC, showed
that in GAD patients affective numbing was associated with
weaker coupling between these regions, with decreased
amygdala activity.116
Fitzgerald et al.114 demonstrated that emotion regula-
tion disturbances in GAD involve excessive reactivity to
negative stimuli and a failure to effectively downregulate
negative affective states. The authors reported that GAD
patients engaged the left amygdala to a greater extent
while viewing negative images, which suggests that these
patients are more responsive to negative stimuli. Further,
Ellard et al.,113 by exploring the mechanisms of emotion
acceptance as an alternate emotion regulation strategy to
worry or emotion suppression in GAD, found that emotion
acceptance resulted in lower ratings of distress than worry
and was associated with increased dorsal ACC activation
and increased VLPFC-amygdala functional connectivity.
Interestingly, two studies also reported that worry was
associated with hyperactivation of amygdala, in both adult
and elderly GAD patients,108,119 as well as of insula and
frontal regions, only in elderly GAD patients,119 compared
to HCs. Similarly, Karim et al.126 showed that worry induc-
tion was associated with increased activation in middle and
superior frontal gyrus as well as in the visual and parietal
cortices compared to non-anxious patients. These results
seemed to be partially in contrast with a previous study
showing the lack of involvement of PFC in suppressing
worry in elderly GAD patients86 and in women with GAD.85
Additionally, an fMRI study carried out by Karim et al,.111
exploring ER in a group of elderly GAD patients, showed a
positive association between ER and global anxiety in the
left parahippocampus, left and right precuneus, and right
superior occipital gyrus, as well as a negative association
between ER and worry severity in precuneus bilaterally.
Finally, Blair et al.117 showed that GAD patients had signi-
ficantly reduced neural modulation in medial PFC and
caudate during the processing of positive events, as well as
increased neural responses to low-impact events in rostral
medial PFC.
In conclusion, the abovementioned findings suggest
that the biological signature of GAD might be related to
deficits in brain regions within the emotional processing
network, which may ultimately result in increased threat
sensitivity paralleled by maladaptive appraisal and exag-
gerated attention allocation, presumably resulting in over-
interpretation and overestimation of threat.
The impact of emotion on cognition in GAD
In recent years, some studies have investigated the
effects of emotion on cognition by means of specific fMRI
tasks. Moon et al.109 explored functional neural activity in
GAD patients using an explicit emotional verbal memory
task with neutral and anxiety-inducing words. The authors
showed that patients with GAD had significantly decrea-
sed activity in limbic regions (hippocampus and middle
cingulate gyrus) and basal ganglia (i.e., the putamen and
head of the caudate nucleus) during processing of both
neutral and anxiety-inducing words, as well as increased
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of anxiety-inducing words. Interestingly, these results
only partially confirmed the evidence reported by a
previous study by the same group, which employed a
similar fMRI task.106 Indeed, in this study, the authors
reported higher activity in the hippocampus and lower
activity in the superior occipital gyrus, superior parietal
gyrus, DLPFC, and precentral gyrus in GAD patients
vs. HCs in response to the emotional distractors in a
working memory task.
Similarly, Park et al.100 found impaired performance in
a working memory task during emotional distracters in
GAD patients, reporting greater activation in brain regions
responsible for the maintenance of goal relevant informa-
tion, including DLPFC, VLPFC, amygdala, and hippo-
campus, in these patients compared to HCs.
Moreover, Ball et al.18 explored the cognitive modula-
tion of emotion in GAD patients by employing a task that
required them to reappraise or maintain emotional
responses to negative images. The authors showed that
GAD patients had less PFC activation than HCs, and
those with the least PFC activation reported the greatest
anxiety severity and impairment, confirming a potential
common neural basis of emotion dysregulation in anxiety
disorders. Furthermore, Cha et al.57 found that during a
threat-associative learning task GAD patients had a signi-
ficant decrease in left anterior hippocampus with cue
repetition compared to HCs. Interestingly, a recent fMRI
study carried out by White et al.118 also showed the pre-
sence of selective deficits in reinforcement-based decision-
making in GAD patients compared to HCs. Indeed, the
authors reported that patients with GAD had a reduced
correlation between reinforcement prediction error and
activity within the VMPFC, the ventral striatum, and other
structures involved in decision-making.
Finally, Diwadkar et al.112 found that GAD patients
have selective impairments in the suppression of
aversive memories through memory control. Specifi-
cally, the authors showed that when asked to suppress
or retrieve memories, GAD patients had hypoactivation
in a large network of brain regions, especially in the
dorsal ACC, the ventral PFC and the cerebellum,
compared to HCs.
In conclusion, although several studies demonstrated
the impact of emotion on cognition in GAD patients, a
general consensus of the brain regions involved in the
interaction between emotional regulation and cognitive
function in this disorder has not been reached yet. Indeed,
a mixture of hypo- and hyper-activations in selective
subcortical and cortical areas has been observed. How-
ever, overall these studies reported the involvement of
amygdala and hippocampus, two interacting brain regions
consistently found to be involved in emotional and cogni-
tive processing.136 Additionally, from the abovementioned
studies also emerged selective deficits in regions within
the PFC, including the DLPFC and VLPFC, areas found
to be a part of the neurobiological models of both emotion
and cognition.137 Therefore, overall, this evidence sug-
gests that GAD patients have selective deficits in key
regions of two well-known interactive systems controlling
affective and cognitive processing, the dorsal executive
and the ventral emotional control systems.138
Resting-state fMRI alterations in GAD
Resting-state fMRI (rs-fMRI) is a sound approach to study
neuropsychiatric disorders.139 Specifically for GAD, a
recent rs-fMRI study showed the presence of aberrant
connectivity between fusiform gyrus and hippocampus/
parahippocampus in GAD patients.102 Also, the authors
reported a positive correlation between abnormal cuneus/
postcentral gyrus and precentral gyrus-calcarine cortex
connections and symptom severity. Similarly, another rs-
fMRI study carried out by Wang et al.105 showed that
GAD patients have 1) higher amplitude of low-frequency
fluctuation in the bilateral DMPFC, bilateral DLPFC, and
left precuneus/posterior cingulate cortex; 2) lower con-
nectivity in prefrontal gyrus; and 3) abnormal seed-based
resting-state functional connectivity within prefrontal-limbic
and cingulate regions coupled with decreased connectivity
in prefrontal gyrus. Notably, the authors reported that
decreased prefrontal-limbic and cingulate connectivity and
increased prefrontal-hippocampal connectivity were corre-
lated with clinical symptoms. Andreescu et al.93 investi-
gated the resting-state functional connectivity patterns in
the DMN in a population of adult and young GAD patients
and showed an anxiety effect on the functional connectivity
between the posterior cingulate and the medial PFC for the
older group relative to the younger participants. Inter-
estingly, the authors also reported that longer duration of
illness was positively correlated with greater functional
connectivity between the posterior cingulate cortex and
insula, whereas worry severity was inversely correlated
with the functional connectivity between the posterior
cingulate cortex and the medial PFC. Also, Qiao et al.123
highlighted stronger functional connectivity in many key
regions, including the amygdala and poster cingulate
cortex, as well as weaker connectivity in frontal and
temporal cortex compared with controls. Furthermore,
the connectivity between the amygdala and all regions of
the DMN and salience networks has been the subject of
a recent investigation which highlighted that, in GAD
patients, deficits in emotional regulation were associa-
ted with altered connectivity between the amygdala
and both these networks.121 Similarly, Liu et al.98 also
found decreased functional connectivity between the left
amygdala and left DLPFC, as well as increased
functional connectivity between the right amygdala and
right posterior and anterior lobes of the cerebellum,
insula, STG, and putamen. Li et al.110 reported increa-
sed functional connectivity between the amygdala and
the temporal pole, as well as decreased connectivity
between the amygdala and DLPFC in GAD patients
compared to HCs. In contrast, preserved connectivity
was found between posterior hippocampus and regions
within the DMN in adult GAD patients.91 Furthermore,
Xia et al.124 showed that GAD patients had decreased
regional homogeneity (ReHo) in middle frontal gyrus, ACC,
and supplementary motor areas, as well as increased
ReHo in temporal and occipital cortices. Finally, Makovac
et al. carried out two studies99,104 demonstrating that GAD
subjects have lower connectivity between the right amyg-
dala and right superior frontal gyrus, right paracingulate/
ACC, and right supramarginal gyrus compared with HCs.
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In conclusion, overall these findings suggest that GAD
is characterized by widely disturbed network connectivity,
mainly between the amygdala and other brain regions.
This supports the hypothesis of a connectivity-based neu-
ral disorder, which may ultimately explain some of the
symptoms observed in GAD patients, including decreased
spontaneity, initiative, insight, judgment, abstraction, per-
severance, and response inhibition.
fMRI alteration in association with drug use in GAD
In the past decades, several randomized controlled studies
have demonstrated that symptoms of anxiety respond
better to antidepressants with relevant serotonin reup-
take inhibitory properties, such as imipramine,140 venla-
faxine,141 paroxetine,142 duloxetine,143 and sertraline127
compared to benzodiazepines. However, neuro-functional
changes underlying the effects of anti-anxiety treatments
have not been fully characterized, although they would
help to understand the neural basis involved in anxiety
symptoms. In this regard, fMRI studies have become
essential to accurately observe and detail the pharmaco-
logical effects of therapies in GAD.
The first fMRI study exploring the effect of a pharma-
cological treatment in GAD patients was carried out by
Hoehn-Saric et al.,73 who employed an auditory task with
statements describing a personal worry. Specifically, the
authors demonstrated that treatment with citalopram
reduced anxiety, psychic, and somatic symptoms. Addi-
tionally, they also reported that after treatment, worry
sentences elicited reduced responses in prefrontal regions,
striatum, insula, and paralimbic regions. A similar approach
was employed by Whalen et al.,69 who explored the effect
of venlafaxine on brain activity in GAD patients while
performing an emotional processing task. The authors
suggested that the magnitude of the treatment response
was predicted by higher pre-treatment reactivity to fearful
faces in rostral ACC and lower reactivity in the amygdala.
Similarly, greater activation in the right VLPFC was also
seen after psychotherapy and fluoxetine treatment.82,92
Nitschke et al.79 showed exaggerated amygdala and
rostral ACC activation during the anticipation of aversive
stimuli in GAD patients prior to treatment with venlafaxine.
Interestingly, the authors also reported that greater rostral
ACC was also associated with a more favorable response
to venlafaxine. Moreover, Andreescu et al.94 explored the
functional connectivity in the salience network and the
executive control network during worry induction and worry
reappraisal in GAD patients before and after pharmacolo-
gical treatment. The authors observed that patients with
GAD, after 12 weeks of treatment with drug therapy,
showed greater connectivity between the DLPFC and
several prefrontal regions during worry reappraisal
compared to pre-treatment.
Interestingly, Kujawa et al.103 reported that greater
activation in prefrontal regions, involved in appraising and
regulating responses to social signals of threat, predicts
better response to SSRI treatment and cognitive-beha-
vioral therapy (CBT) in anxious youth. This has also been
highlighted by a study carried out by Burkhouse et al.,107
who showed that in some patients less recruitment of
superior frontal gyrus, encompassing the dorsal ACC
and DMPFC, during implicit emotion processing, predicts
greater reduction in youth anxiety symptoms after treat-
ment with SSRI. Additionally, a more recent study carried
out by the same research group reported that after
treatment with sertraline or CBT, GAD patients showed
increased activation in rostral ACC, a region responsible
for better response to stimuli relevant to the threat.127
Finally, Brown et al.97 investigated the temporal pattern
of brain response to emotional stimuli during 28 days
of alprazolam (ALZ) treatment among GAD patients.
Brain activation in the amygdala, during an emotion face-
matching task, and in the insula, during an affective
stimulus expectancy task, was reduced 1 hour after ALZ
administration, but returned to baseline levels at day 28.
These results are consistent with the notion that the neural
mechanisms supporting sustained treatment effects of
benzodiazepines in GAD differ from those underlying their
acute effects. However, reductions in blood oxygen level
dependent response in these regions did not persist over
the 28 days of ALZ administration despite continued
improvement of symptoms.
In conclusion, these findings suggest that neuroima-
ging investigations may be a useful tool for predicting how
GAD patients will respond to treatment. Specifically, they
suggest that GAD is amenable to psychopharmacologic
treatment and that benzodiazepines are not as effective in
controlling psychic symptoms of anxiety as antidepres-
sants such as venlafaxine and paroxetine.141,142
Specifically, from the available evidence, it emerges that
threat processing and the underlying neurocircuitry are
relevant to treatment response in anxiety. Interestingly, the
abovementioned studies investigated either the role of the
brain in response to treatment or the effects exerted by
specific pharmacological treatments on brain structures.
With regard to the first working hypothesis, the available
evidence, regardless of the treatment employed, supported
the idea that specific brain regions, including the DLPFC
and VLPFC, are associated with better treatment response,
ultimately suggesting that the identification of key brain
structures associated with treatment response may, there-
fore, allow the development of more targeted and efficient
treatments for GAD. Finally, with regard to the second work-
ing hypothesis, which explores the effect that some drugs
have on brain structures, overall the results suggest that
the first line treatments of GAD, e.g., antidepressants,
seem to have similar effects on specific brain structures
involved in emotional processing, an ability that is consis-
tently shown to be impaired in GAD patients. Please see
Figure 2 depicting the neural regions consistently found
altered in GAD in structural and functional MRI studies.
Limitations
It should be noted that most available findings are
preliminary and limited by major methodological issues.
First, most studies enrolled small groups of patients, often
with comorbid depression or other anxiety disorders (i.e.,
PD or social phobia), which may limit the generalizabi-
lity of the findings. However, although larger and more
homogenous samples of GAD patients would have been
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beneficial, the exclusion of patients with comorbid diagno-
ses would have been a difficult challenge, especially
because comorbidities frequently occur in GAD. Second,
age differences among GAD patients in individual studies
also complicate the interpretation of results. However, it is
important to point out that the presence of neuroimaging
investigations in both adults and pediatric populations is
also an important strength, since the combination of
results from these age groups could provide important
insights on the pathophysiology of GAD. Indeed, overall,
neuroimaging studies with adult and pediatric populations
reported converging evidence of deficits in emotional
processing, mainly due to prefrontal-limbic dysfunctions in
GAD patients. Third, many studies used different medi-
cations, and pre- and post-treatment evaluation was not
always possible. Fourth, most studies had a cross-sectional
design and therefore it was not possible to determine
whether brain abnormalities are an epiphenomenon of
current psychiatric states. Fifth, functional studies were
conducted using different activation paradigms (auditory
or visual stimuli, emotional conflicts, monetary incentive
delay task, decision-making task), therefore producing
heterogeneous results. Finally, differences in acquisition
equipment (1.5 vs. 3 Tesla scanner) and pre-processing
methodologies may explain the high heterogeneity in
terms of the results reported by original studies.
Conclusions
To date, several imaging studies have been carried out in
GAD. These studies have produced a better understand-
ing of the pathophysiological mechanisms involved in this
disorder by suggesting abnormalities in key brain regions
within the prefrontal-limbic network, including the DLPFC,
ACC, amygdala, and VLPFC, ultimately strengthening a
modular model for anxiety symptoms. From this perspec-
tive, one should bear in mind that the amygdala, cingulate,
and PFC are strictly connected99,104,144,145 and are mainly
involved in modulating social processing, recognition of
emotional expressions, and fear-related behavior.36,145-149
However, a general consensus on the morpho-func-
tional alterations characterizing GAD has not yet been
reached, although hypoactivation of the PFC18,85,113 and
hyperactivation of the amygdala98,112,115,149 are among
the most consistent findings. These results are not sur-
prising, since these two regions are closely intertwined.
Indeed, the PFC regulates emotional distraction and
maintains ongoing performance via its modulatory inter-
actions with the amygdala; the PFC is also thought to
implement controls that minimize performance distur-
bances from threat-induced anxiety and target distracting
stimuli by modulating activity in regions involved in threat
detection, such as the amygdala.92,113,115 This implies
that the amygdala-PFC functional connectivity may help
maintain performance in the presence of anxiety induced
by threat. Therefore, the integrity of this modulation may
help maintain the performance when threat-induced anxiety
stimuli occur, by minimizing alterations and malfunctions
caused by the activation of anxiety circuits. Interestingly,
animal models seem to further confirm the importance of
these structures in mediating emotional states, including
anxiety. Indeed, they consistently suggest an important
role played by limbic circuits, and especially the amyg-
dala, in the response to fear.9,12,14
Furthermore, from the abovementioned neuroimaging
studies it also emerges that GAD seems to be character-
ized by abnormalities in selective brain regions, including
amygdala, ACC, DLPFC, and VLPFC, within the right
hemisphere. Various studies demonstrate a functional
lateralization of the amygdala, with the functional link
between the right amygdala and PFC being preferen-
tially involved in anxiety.53 For example, Lee et al.150
showed that viewing negative emotional images corre-
lated with greater activation of the right hemisphere than
left hemisphere. Right hemisphere involvement was
predominantly observed by structural studies, ultimately
supporting the hypothesis that right hemisphere alterations
Figure 2 Brain regions consistently found to be involved in generalized anxiety disorder from structural and functional MRI studies.
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may be crucial for the pathophysiology of GAD, even
during neurodevelopment.
In conclusion, brain imaging investigations are useful to
elucidate in vivo brain correlates of GAD, which may
ultimately be beneficial for more targeted pharmacological
interventions. However, future cross-sectional and long-
itudinal neuroimaging studies, coupled with cognitive and
genetic investigations, on un-medicated juvenile and adult
patients, children at high risk of GAD as well as unaffected
family members are warranted to further characterize
the link between neural circuitries and the behavioral
phenotype.
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